Market Research Report

A quick peek into the report

Global Rare Disease Diagnostics Market

Focus on Disease, Trait Type, Products, Age Group, Test Type, Technology, End User, Country Data (15 Countries), and Competitive Landscape - Analysis and Forecast, 2020-2030

 
Some Faq's

Frequently Asked Questions

The rare disease diagnostics market is expected to reach $70.69 billion by 2030, growing at a CGR of 8.57% during the forecast period, 2020-2030.

The possible factors driving the growth of the market include rising prevalence of genetic disorders, increasing research and development in the field of rare disease diagnostics, rare genome projects leading to rise in awareness regarding treatment of disease, and    commitment of big pharma and biotech companies to rare diseases.

Diseases for which rare disease diagnostic can be used include gastroenterology disease, endocrine and metabolism disorders disease, cardiovascular disorders, neurology disease, hematology and oncology disease, and dermatology disease.

End-user industries covered under rare disease diagnostics market include hospital laboratories, diagnostics laboratories, genetic testing laboratories, cancer research laboratories.

Some of the key players operating in the market include 23andMe Inc., 3billion, Inc., Agilent Technologies, Inc., Beijing Genomics Institute (BGI), CENTOGENE N.V., Eurofins Scientific SE, GENEWIZ, Inc., Illumina, Inc., In-Depth Genomics, Invitae Corporation, Laboratory Corporation of America Holdings, OPKO Health, PerkinElmer, Inc., Quest Diagnostics Incorporated, Travere Therapeutics, Inc.

Similar Product

You may also like

Published Year: 2020

Global Hereditary Genetic Testing Market: Focus on Product, Sample, Technology, Genetic Testing Type

The global market for hereditary genetic testing is predicted to grow at a CAGR of 13.59% over ...

Published Year: 2020

Global Whole Genome and Exome Sequencing Market: Focus on Product, Workflow, Application, End User,

The global market for whole genome and exome sequencing is predicted to grow at a CAGR of ...